Organic Communications

A scientific open access journal in the field of synthetic organic chemistry and polymers
Editor-in-Chief: Hasan Seçen
Book Review and Review Article Editor: Turan Ozturk
Synthetic Polymer Section Editor: Mehmet S. Eroglu
Editor: Synthesis of Natural Products: Ahmet C Goren


Review Article

Comprehensive review on repurposing of approved medicine in the management of COVID-19 infection

Org. Commun. (2022) in press ; 1 - 31
by Darshini Patel , Umang Shah , Arya Patel , Sandip Patel , Mehul Patel , Ashish Patel , Swayamprakash Patel , Nilay Solanki and Nilesh Pandey

The SARS-CoV-2 virus, accountable for the COVID-19 pandemic, is now sweeping the globe. As a result, as this disease resists testing and adoption of new treatments, repositioning existing medications may provide a quick and appealing method with established safety, features, and dose used. They are not, however, specific or focused. However, numerous medications have been studied for their efficacy and safety in treatment of COVID-19, with the majority currently undergoing clinical trials. The goal is to rapidly expand novel preventative and therapeutic medications, as well as to apply preventive methods such as early patient identification, isolation, and treatment. Moreover, reducing transmission through physical contact is also important. In the fight against this dangerous disease, finding the proper treatment is crucial. This article summarizes several anti-malarial, anti-parasitic, monoclonal antibodies, immunosuppressant, and immunomodulating agents in clinical trials for COVID-19. The purpose of this article is to evaluate and explore the potential roles of several medications now utilized in COVID-19.

COVID-19 SARS-CoV-2 spike protein drug repurposing ACE coronavirus
Available online: January 02, 2022
© ACG Publications. All rights reserved.